Li-fraumeni Syndrome
📧 Sign up to get email alerts when something new happens for Li-fraumeni Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
The NHLBI-funded clinical trial aims to characterize patients with uncommon cardiovascular presentations and diseases, including obesity-rel…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Clinical Genetics Branch Eligibility Screening Survey
National Cancer Institute conducts an eligibility screening survey for a clinical trial spanning multiple cancer predisposition conditions, …
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Familial Investigations of Childhood Cancer Predisposition
An ongoing St. Jude-led clinical trial is investigating familial cancer predisposition syndromes in children and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Willingness to Participate in a Trial Comparing Standard Genetic Counseling Versus Personalized Genetic Counseling
This clinical trial update reports that a study comparing standard genetic counseling to personalized genetic counseling for Li-Fraumeni syn…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Li-Fraumeni & TP53 (LiFT UP): Understanding and Progress
This clinical trial update describes the Li-Fraumeni & TP53 (LiFT UP) study focused on understanding TP53-related Li-Fraumeni syndrome and h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Clinical and Genetic Studies of Li-Fraumeni Syndrome
Ongoing clinical and genetic studies on Li-Fraumeni syndrome, a TP53 mutation–associated cancer predisposition, with recruitment currently o…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Screening With Whole Body MRI For Detection Of Primary Tumors In Children And Adults With Li-Fraumeni Syndrome (LFS) And Other Cancer Predisposition Syndromes [NA]
A Dana-Farber Cancer Institute trial is evaluating whole-body MRI screening to detect primary tumors in children and adults with Li-Fraumeni…
-
CLINICAL_TRIALS trial_result · 2025-12-10Clinical Trial Update: Exploring How to Adapt an Evidence-Based Mindful Self-Compassion Program for Young Adults With Li-Fraumeni Syndrome
Completed clinical trial evaluating an evidence-based mindful self-compassion program for young adults with Li-Fraumeni Syndrome. The study …
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Registry of Li Fraumeni and Li Fraumeni Like Syndromes
A registry study for Li-Fraumeni syndrome and Li-Fraumeni-like syndrome is currently recruiting at Istituto Ortopedico Rizzoli.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Li-Fraumeni Syndrome/TP53 Biobank
An ongoing Li-Fraumeni syndrome TP53 biobank trial is recruiting participants.
-
CLINICAL_TRIALS research · 2024-12-13Clinical Trial Update: Li-Fraumeni Syndrome Imaging Study [NA]
This document indicates an imaging study for Li-Fraumeni syndrome is currently enrolling by invitation at The Hospital for Sick Children.
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Video Capsule Examination in Patients With Lynch Syndrome [NA]
Status update for NCT06712095 shows recruitment underway for a study assessing video capsule examination in patients with Lynch syndrome and…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: LIFSCREEN : Evaluation of Whole Body MRI for Early Detection of Cancers in Subjects With P53 Mutation (Li-Fraumeni Syndrome) [Phase 3]
Phase 3 trial evaluating whole-body MRI for early cancer detection in Li-Fraumeni syndrome subjects has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Nicotinamide Riboside on Mitochondrial Function in Li-Fraumeni Syndrome [Phase 1, Phase 2]
Phase 1/2 trial evaluating nicotinamide riboside for mitochondrial function in Li-Fraumeni syndrome has completed with results posted.
-
EMA withdrawal · 2009-12-19EMA Application withdrawn: Advexin — Gendux Molecular Limited
The EMA status shows the Advexin application has been withdrawn for Li-Fraumeni Syndrome by Gendux Molecular Limited.